iX Biopharma42C 
$0.023.85%24h
3.85%24h
Global rank31059
Market cap$15.96M
Change 7d3.85%
YTD Performance-40.00%
SP500 benchmarkUnderperform
P/E0
P/S3.50
Revenue$4.56M
Earnings-$7.42M
Dividend yield-
Main Sector
Healthcare
Category
iX Biopharma 42C Operating Margins
Operating Margin in 2022: -1.61%
According to iX Biopharma latest financial reports the company has an operating margin of -1.61%, an decrease of -4377.50% to 2022. At the end of 2022 company had an operating margin of 0.04%.
iX Biopharma Operating Margin from 2020 to 2024
-
Value:-
42C Operating Margin History by year
| Year | Operating Margin | Change |
|---|---|---|
| 2023 | -1.61% | -4377.50% |
| 2022 | 0.04% | -100.58% |
| 2021 | -6.48% | -44.20% |
| 2020 | -11.61% | - |
View the highest operating margin companies 
